GlassScriptPhysician profile
Andrew Jacob Chapel
NPI 1619406352
$8,468.70
in general payments reported to CMS, 2019-2025
36 companies · $1,518 in 2025
The $1,518 reported for 2025 was more than what 79% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $340 · 2020: $378 · 2021: $1,132 · 2022: $2,097 · 2023: $553 · 2024: $2,452 · 2025: $1,518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,522.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $979.20 | 2020-2024 | Cardiomems |
| Boston Scientific Corporation | $815.26 | 2021-2024 | Watchman Flx |
| Edwards Lifesciences Corporation | $754.93 | 2023-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Novartis Pharmaceuticals Corporation | $669.15 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $666.76 | 2022-2024 | Xarelto |
| Amgen INC. | $637.16 | 2022-2025 | Repatha, Repatha |
| Medtronic, INC. | $629.00 | 2021-2024 | Micra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $626.20 | 2024-2025 | Lifevest |
| W. L. Gore & Associates, INC. | $307.56 | 2022 | |
| Pfizer INC. | $255.59 | 2019-2025 | |
| Amarin Pharma, INC. | $225.68 | 2019 | |
| Cleerly, INC. | $180.33 | 2024 | Cleerly Ischemia, Cleerly Labs |
| Philips North America LLC | $172.76 | 2021-2024 | (Ck4) Mcot, (Cm9) Amb Mon & Diag Und |
| Cardiovascular Systems INC. | $172.45 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $143.38 | 2024-2025 | Camzyos, Eliquis |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Chapel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.